Sintecabio ranked among the top searched stocks on 9 days within the past month.


As of 10:35 AM on the 5th, Sintecabio is trading at 36,200 KRW, down 6.94% from the previous day. This represents a 149.66% increase compared to September 2. Sintecabio is known as a genomic big data research company.

Over the past 5 days, individual investors have net purchased 57,640 shares, while foreigners and institutions have net sold 59,425 shares and net purchased 2,690 shares, respectively.


On September 29, Sintecabio became a market issue with the headline "COVID-19 treatment efficacy Remdesivir doubled, hitting the upper price limit."



※Source: AI Investment Assistant AI Lasso


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing